ADVANCES IN MUCOADHESIVE IN SITU GEL-BASED NASAL DRUG DELIVERY SYSTEMS: FORMULATION AND THERAPEUTIC APPLICATION
Nasal drug delivery is an effective and non-invasive route of drug administration that offers rapid drug absorption, improved bioavailability, and avoidance of first-pass metabolism. However, conventional nasal dosage forms such as drops and sprays have certain limitations, including rapid mucociliary clearance, enzymatic degradation, limited residence time, and poor absorption of certain drugs. To overcome these limitations, mucoadhesive in situ gel systems have emerged as a promising approach for nasal drug delivery. In situ gels are administered in the form of a liquid and undergo sol-to-gel transformation after coming into contact with physiological conditions such as temperature, pH, or ions present in the nasal cavity. The incorporation of mucoadhesive polymers helps the formulation adhere to the nasal mucosa, prolonging drug residence time and improving drug absorption. Various natural and synthetic polymers, such as chitosan, carbopol, poloxamer, gellan gum, xanthan gum, and sodium alginate, are used in the development of these systems. This review focuses on the anatomy and physiology of the nasal cavity, barriers to nasal drug delivery, mechanisms of mucoadhesion and in situ gel formation, different approaches, polymers, formulation methods, and evaluation parameters. Mucoadhesive in situ gel systems represent a promising strategy for improving the efficiency of nasal drug delivery through controlled and sustained drug release.
Authors
- Aishwarya Deshmukh
- Sakshi Raut
- Rahul S. Bijwar
- Krutika Sanjay Bisen
- Simran Yunus Sheikh
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24415346
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00